Dietary sparassis crispa (Hanabiratake) ameliorates plasma levels of adiponectin and glucose in type 2 diabetic mice

Journal of Health Science

Volumn 56, Issue 5, 2010, Pages 541-546

  Yamamoto, Kyosuke ^a   Kimura, Takashi ^a  

^a UNITIKA LTD   (Japan)

Author keywords

Adiponectin; KK ay mice; Sparassis crispa (Hanabiratake)

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CELL SIZE; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; MOUSE; MUSHROOM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; SPARASSIS CRISPA; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

BASIDIOMYCOTA; MUS; SPARASSIS CRISPA;

EID: 78049269013     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.56.541     Document Type: Article

References (23)

1. Scherer, P. E. (2006) Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes, 55, 1537-1545.
2. Berg, A. H., Combs, T. P. and Scherer, P. E. (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endcrinol. Metab., 13, 84-89.
3. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792.
4. Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y. and Libby, P. (2006) Adiponectin: a key adipocytokine in metabolic syndrome. Clin. Sci., 110, 267-278.
5. Szmitko, P. E., Teoh, H., Stewart, D. J. and Verma, S. (2007) Adiponectin and cardiovascular disease: state of the art? Am. J. Physiol. Heart Circ. Physiol., 292, H1655-H1663.
6. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K. and Kadowaki, T. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med., 13, 332-339.
7. Miura, T., Kubo, M., Itoh, Y., Iwamoto, N., Kato, M., Sang, R. P., Ukawa, Y., Kita, Y. and Suzuki, I. (2002) Antidiabetic activity of Lyophyllum decastes in genetically type 2 diabetic mice. Biol. Pharm. Bull., 25, 1234-1237.
8. Hong, L., Xun, M. and Wutong, W. (2007) Antidiabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J. Pharm. Pharmacol., 59, 575-582.
9. Kim, Y. W., Kim, K. H., Choi, H. J. and Lee, D. S. (2005) Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol. Lett., 27, 483-487.
10. Imazeki, R. and Hongo, T. (1998) Colored Illustrations of Mushrooms of Japan, Vol. II, Hoikusha Press, Osaka, p. 109.
11. Ohno, N., Miura, N. N., Nakajima, M. and Yadomae, T. (2000) Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull., 23, 866-872.
12. Tada, R., Harada, T., Nagi-Miura, N., Adachi, Y., Nakajima, M., Yadomae, T. and Ohno, N. (2007) NMR characterization of the structure of a beta- (1→3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res., 342, 2611-2618.
13. Yamamoto, K., Kimura, T., Sugitachi, A. and Matsuura, N. (2009) Anti-angiogenic and antimetastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Biol. Pharm. Bull., 32, 259-263.
14. Hasegawa, A., Yamada, M., Dombo, M., Fukushima, R., Matsuura, N. and Sugitachi, A. (2004) Sparassis crispa as biological response modifier. Jpn. J. Cancer Chemother., 31, 1761-1763.
15. Yao, M., Yamamoto, K., Kimura, T. and Dombo, M. (2008) Effects of Hanabiratake (Sparassis crispa) on allergic rhinitis in OVA-sensitized mice. Food Sci. Technol. Res., 14, 589-594.
16. Kwon, A. H., Qiu, Z., Hashimoto, M., Yamamoto, K. and Kimura, T. (2009) Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats. Am. J. Surg., 197, 503-509.
17. Harada, T., Miura, N., Adachi, Y., Nakajima, M., Yadomae, T. and Ohno, N. (2002) Effect of SCG, 1,3-beta-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol. Pharm. Bull., 25, 931-939.
18. Maeda, N., Shimomura, I., Kisida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T. and Matsuzawa, Y. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med., 8, 731-737.
19. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. and Kadowaki, T. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941-946.
20. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 116, 1784-1792.
21. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kisida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I. and Matsuzawa, Y. (2001) PPARγ ligands increase expression and plasma concentrations of adiponectin, an adiposederived protein. Diabetes, 50, 2094-2099.
22. Nawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H., Rossetti, L. and Scherer P. E. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor-γ agonists. J. Biol. Chem., 281, 2654-2660.
23. Qi, L., Rimm, E., Liu, S. M., Rifai, N. and Hu, F. B. (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care, 2, 1022-1028.